Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T37.2X6SBillable
Underdosing of antimalarials and drugs acting on other blood protozoa, sequela
- T37.3X5ABillable
Adverse effect of other antiprotozoal drugs, initial encounter
- T37.3X5DBillable
Adverse effect of other antiprotozoal drugs, subsequent encounter
- T37.3X5SBillable
Adverse effect of other antiprotozoal drugs, sequela
- T37.3X6ABillable
Underdosing of other antiprotozoal drugs, initial encounter
- T37.3X6DBillable
Underdosing of other antiprotozoal drugs, subsequent encounter
- T37.3X6SBillable
Underdosing of other antiprotozoal drugs, sequela
- T37.4X5ABillable
Adverse effect of anthelminthics, initial encounter
- T37.4X5DBillable
Adverse effect of anthelminthics, subsequent encounter
- T37.4X5SBillable
Adverse effect of anthelminthics, sequela
- T37.4X6ABillable
Underdosing of anthelminthics, initial encounter
- T37.4X6DBillable
Underdosing of anthelminthics, subsequent encounter
- T37.4X6SBillable
Underdosing of anthelminthics, sequela
- T37.5X5ABillable
Adverse effect of antiviral drugs, initial encounter
- T37.5X5DBillable
Adverse effect of antiviral drugs, subsequent encounter
- T37.5X5SBillable
Adverse effect of antiviral drugs, sequela
- T37.5X6ABillable
Underdosing of antiviral drugs, initial encounter
- T37.5X6DBillable
Underdosing of antiviral drugs, subsequent encounter
- T37.5X6SBillable
Underdosing of antiviral drugs, sequela
- T37.8X5ABillable
Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
- T37.8X5DBillable
Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.8X5SBillable
Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
- T37.8X6ABillable
Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter
- T37.8X6DBillable
Underdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.8X6SBillable
Underdosing of other specified systemic anti-infectives and antiparasitics, sequela
- T37.95XABillable
Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
- T37.95XDBillable
Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
- T37.95XSBillable
Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
- T37.96XABillable
Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter
- T37.96XDBillable
Underdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter
- T37.96XSBillable
Underdosing of unspecified systemic anti-infectives and antiparasitics, sequela
- T38.0X5ABillable
Adverse effect of glucocorticoids and synthetic analogues, initial encounter
- T38.0X5DBillable
Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
- T38.0X5SBillable
Adverse effect of glucocorticoids and synthetic analogues, sequela
- T38.0X6ABillable
Underdosing of glucocorticoids and synthetic analogues, initial encounter
- T38.0X6DBillable
Underdosing of glucocorticoids and synthetic analogues, subsequent encounter
- T38.0X6SBillable
Underdosing of glucocorticoids and synthetic analogues, sequela
- T38.1X5ABillable
Adverse effect of thyroid hormones and substitutes, initial encounter
- T38.1X5DBillable
Adverse effect of thyroid hormones and substitutes, subsequent encounter
- T38.1X5SBillable
Adverse effect of thyroid hormones and substitutes, sequela
- T38.1X6ABillable
Underdosing of thyroid hormones and substitutes, initial encounter
- T38.1X6DBillable
Underdosing of thyroid hormones and substitutes, subsequent encounter
- T38.1X6SBillable
Underdosing of thyroid hormones and substitutes, sequela
- T38.2X5ABillable
Adverse effect of antithyroid drugs, initial encounter
- T38.2X5DBillable
Adverse effect of antithyroid drugs, subsequent encounter
- T38.2X5SBillable
Adverse effect of antithyroid drugs, sequela
- T38.2X6ABillable
Underdosing of antithyroid drugs, initial encounter
- T38.2X6DBillable
Underdosing of antithyroid drugs, subsequent encounter
- T38.2X6SBillable
Underdosing of antithyroid drugs, sequela
- T38.3X5ABillable
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
- T38.3X5DBillable
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
- T38.3X5SBillable
Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
- T38.3X6ABillable
Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
- T38.3X6DBillable
Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
- T38.3X6SBillable
Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
- T38.4X5ABillable
Adverse effect of oral contraceptives, initial encounter
- T38.4X5DBillable
Adverse effect of oral contraceptives, subsequent encounter
- T38.4X5SBillable
Adverse effect of oral contraceptives, sequela
- T38.4X6ABillable
Underdosing of oral contraceptives, initial encounter
- T38.4X6DBillable
Underdosing of oral contraceptives, subsequent encounter
- T38.4X6SBillable
Underdosing of oral contraceptives, sequela
- T38.5X5ABillable
Adverse effect of other estrogens and progestogens, initial encounter
- T38.5X5DBillable
Adverse effect of other estrogens and progestogens, subsequent encounter
- T38.5X5SBillable
Adverse effect of other estrogens and progestogens, sequela
- T38.5X6ABillable
Underdosing of other estrogens and progestogens, initial encounter
- T38.5X6DBillable
Underdosing of other estrogens and progestogens, subsequent encounter
- T38.5X6SBillable
Underdosing of other estrogens and progestogens, sequela
- T38.6X5ABillable
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
- T38.6X5DBillable
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
- T38.6X5SBillable
Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
- T38.6X6ABillable
Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
- T38.6X6DBillable
Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
- T38.6X6SBillable
Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
- T38.7X5ABillable
Adverse effect of androgens and anabolic congeners, initial encounter
- T38.7X5DBillable
Adverse effect of androgens and anabolic congeners, subsequent encounter
- T38.7X5SBillable
Adverse effect of androgens and anabolic congeners, sequela
- T38.7X6ABillable
Underdosing of androgens and anabolic congeners, initial encounter
- T38.7X6DBillable
Underdosing of androgens and anabolic congeners, subsequent encounter
- T38.7X6SBillable
Underdosing of androgens and anabolic congeners, sequela
- T38.805ABillable
Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
- T38.805DBillable
Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
- T38.805SBillable
Adverse effect of unspecified hormones and synthetic substitutes, sequela
- T38.806ABillable
Underdosing of unspecified hormones and synthetic substitutes, initial encounter
- T38.806DBillable
Underdosing of unspecified hormones and synthetic substitutes, subsequent encounter
- T38.806SBillable
Underdosing of unspecified hormones and synthetic substitutes, sequela
- T38.815ABillable
Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
- T38.815DBillable
Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
- T38.815SBillable
Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
- T38.816ABillable
Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter
- T38.816DBillable
Underdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
- T38.816SBillable
Underdosing of anterior pituitary [adenohypophyseal] hormones, sequela
- T38.895ABillable
Adverse effect of other hormones and synthetic substitutes, initial encounter
- T38.895DBillable
Adverse effect of other hormones and synthetic substitutes, subsequent encounter
- T38.895SBillable
Adverse effect of other hormones and synthetic substitutes, sequela
- T38.896ABillable
Underdosing of other hormones and synthetic substitutes, initial encounter
- T38.896DBillable
Underdosing of other hormones and synthetic substitutes, subsequent encounter
- T38.896SBillable
Underdosing of other hormones and synthetic substitutes, sequela
- T38.905ABillable
Adverse effect of unspecified hormone antagonists, initial encounter
- T38.905DBillable
Adverse effect of unspecified hormone antagonists, subsequent encounter
- T38.905SBillable
Adverse effect of unspecified hormone antagonists, sequela
